Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06603090 · ClinicalTrials.gov registry record · NA
Text4Vax: Text Message Reminders for Pediatric COVID-19 and Influenza Vaccines 2024-25 Season
A NA study, sponsored by Columbia University.
- Completed
- Registry status
- NA
- Development phase
- 66,147
- Enrollment target
NCT06603090: Completed NA study, sponsored by Columbia University.
NCT06603090 is a NA study that has completed, run by Columbia University. The registered enrollment target is 66,147 participants, above the 1,402-participant average among 58,714 other NA trials with a reported enrollment target (4618% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06603090, a NA study, has completed, sponsored by Columbia University.
- COMPLETED
- Registry status
- NA
- Development phase
- 66,147 participants
- Enrollment target
Study Summary
This multi-site study assesses the impact of text message reminders on the receipt of COVID-19 and influenza text message reminders takes place primarily in practices from the American Academy of Pediatrics (AAP) Pediatric Research in Office Settings (PROS) network.
Primary Outcome
Days from study start to influenza vaccine up to December 31 each year
Interventions
- BEHAVIORAL Text message influenza vaccine reminders
- BEHAVIORAL Text message COVID-19 vaccine reminders
- BEHAVIORAL Text message influenza and COVID-19 vaccine reminders
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 66,147 participants |
| Start Date | 2024-10-02 |
| Est. Completion | 2025-04-30 |
| Phase | NA |
What the finished NCT06603090 record still lists
NCT06603090 is an interventional study that assigns participants to a tested intervention. Its 66,147 participants enrollment target places it among the larger protocols in the corpus, above the 1,402-participant average among 58,714 other NA trials with a reported enrollment target (4618% higher).
The record links to 0 conditions, and to 3 interventions - of which Text message influenza vaccine reminders is the first listed.
NCT06603090 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06603090 about?
NCT06603090 is a clinical study titled "Text4Vax: Text Message Reminders for Pediatric COVID-19 and Influenza Vaccines 2024-25 Season". This multi-site study assesses the impact of text message reminders on the receipt of COVID-19 and influenza text message reminders takes place primarily in practices from the American Academy of Pediatrics (AAP) Pediatric Research in Office Settings (PROS) network.
What is the current status of trial NCT06603090?
This trial is currently completed. It is a NA study. The enrollment target is 66,147 participants. The study started on 2024-10-02. Estimated completion is 2025-04-30.
What interventions are being tested in trial NCT06603090?
The interventions under investigation include: Text message influenza vaccine reminders (BEHAVIORAL), Text message COVID-19 vaccine reminders (BEHAVIORAL), Text message influenza and COVID-19 vaccine reminders (BEHAVIORAL).
Who is sponsoring clinical trial NCT06603090?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06603090's enrollment target sits among peer trials
66,147 4th of 2000 higher than 1,997 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04473833 · 65,000 participants · NA
Transvaginal Ultrasonography as a Screening Method for Ovarian Cancer
- NCT00009633 · 68,000 participants
Follow-up Visit of High Risk Infants
- NCT06903897 · 68,000 participants · NA
Social Needs Screening and Chronic Diseases Study (WE CARE)
- NCT05128006 · 63,200 participants
Direct-to-patient Teledermatology and Computer-assisted Diagnosis
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI